KHIDI, provides various services on technology transfer. KHIDI will license and commercialise several technologies of KHIDI's client companies via collaboration with overseas partners. More
Samyang Pharmaceuticals Business Unit, in collaboration with Samyang's pharmaceutical research center, is engaged in the development and marketing of novel drug delivery systems and medical devices. More
CrystalGenomics is a structure based drug discovery company, generating novel small molecular therapeutics such as antibiotics, anti-cancer and quality of life improving drugs. More
Discovery and development of new biological drugs addressing significant unmet medical needs in the areas of difficult-to-treat diseases (e.g., cancers, inflammatory/immune disease, and rare diseases) More
Structural Chemoproteomics Based Drug Discovery with 2nd generation
COX-2 inhibitor in phase II,HDAC inhibitor and ENR inhibitor in preclinical stage. More